Decoding Patent and Regulatory Exclusivities Seminar

Understanding the interplay between patent rights and regulatory exclusivities is particularly important for early stage life science companies. Whether you are beginning the patent protection process or have existing patent rights, this seminar will provide a comprehensive presentation on the various intellectual property and regulatory strategies a branded company should consider in anticipation of partnering discussions, FDA approval and potential generic challenges, from both the litigation and strategic development perspectives.

Goodwin Procter partners Daryl Wiesen and Theresa Kavanaugh will lead the presentation.